More than 1 million doses of the Bulgarian diphtheria and tetanus vaccine (ADP-M) with a reduced antigen content, procured by the state-owned enterprise Medical Procurement of Ukraine (MPU), have been delivered to Ukraine.
According to the Ministry of Health’s website, the next delivery will be 18,300 doses.
The Ministry of Health specifies that 75% of the vaccine will be distributed to medical institutions in the regions, and 25% of the vaccine will be stored at the national level as a reserve and can be distributed to the regions if necessary.
The vaccine is intended for free vaccinations in the diphtheria and tetanus preventive vaccination schedule and contains purified antitoxins.
Vaccination for the prevention of diphtheria and tetanus with ADP-M vaccine is carried out at the age of 16 and during the revaccination of adults.
“Despite the military challenges, the Ministry of Health managed to secure the supply of vaccines for routine vaccination,” commented Deputy Minister of Health, Chief Medical Officer Ihor Kuzin.
The vaccination calendar includes vaccinations against 10 infectious diseases: tuberculosis, hepatitis B, measles, mumps, rubella, diphtheria, tetanus, pertussis, polio and hib infection.
Ukraine has received 203 thousand doses of Pfizer’s COVID-19 vaccine, adapted to protect against the Omicron strain, for free vaccinations from the United Nations Children’s Fund UNICEF as part of the international COVAX initiative.
According to the Ministry of Health on its website, the vaccine will be distributed to all regions. The storage and transportation of vaccines will be ensured by specialists of the regional centers for disease control and prevention (CDC) in compliance with the requirements of the cold chain.
The vaccine is intended for booster vaccination of those who have already received the primary COVID-19 vaccination.
According to Ihor Kuzin, Deputy Minister of Health, Chief State Sanitary Doctor of Ukraine, more than 13 strains of the SARS-CoV-2 virus are currently circulating in Ukraine, and all detected mutations are deviations from the Omicron strain.
In total, since the beginning of the epidemic season in Ukraine in October, more than a million Ukrainians have fallen ill with SARS, influenza and COVID-19.
The general recommended course of primary vaccination against COVID-19 and the first booster is three vaccinations. The first booster is administered five months after the initial vaccination.
On Sunday, December 12, two new batches of CoronaVac vaccine against coronavirus infection (COVID-19) will be delivered to Ukraine, the press service of the pharmaceutical company Lekhim has said.
“The Lekhim Group of Companies informs that on Sunday, December 12, 2021, two deliveries of CoronaVac vaccine for the prevention of COVID-19 [produced by Sinovac Life Science Co., Ltd.] will arrive in Ukraine,” the company’s website says.
It is noted that 2.447 million doses will arrive on Sunday.
“Estimated time of arrival is 12:00 – 2 million doses, and 19:20 – 447,000 doses,” the press service added.
It is also reported that the supply of the vaccine is carried out under a supplementary agreement to the agreement between Sinovac Life Science Co., Ltd. and PrJSC Lekhim.
The rules of entry to the Czech Republic for vaccinated Ukrainians have been preserved, Ukrainian Foreign Minister Dmytro Kuleba has said.“The Czech Republic remains open for travel of vaccinated Ukrainians on the same conditions as before. We continue to work with partners in the EU countries to preserve the freedom of movement of our citizens,” he wrote on his Twitter account. All conditions of entry are available on the website of the Consular Service of Ukraine at: https://tripadvisor.mfa.gov.
About 30% of adult Ukrainians have received at least one dose of a COVID-19 vaccine, Health Minister Viktor Liashko has said.
“A record daily number of 291,293 COVID-19 vaccine shots have been administered in Ukraine today. Owing to this, we have reached the figure of 30% of the adult population who have been vaccinated with at least one dose,” Liashko said at a press briefing on Wednesday.
Ukraine is using COVID-19 vaccines approved by the World Health Organization (WHO), and over 9 million vaccine doses are currently available at vaccination stations across the country, he said.
“We have vaccine supplies planned week by week for the period up to the end of the year. These include both vaccines procured using state budget funds and those shipped to the country owing to its participation in the global COVAX mechanism,” he said.
In line with the contracts concluded for the vaccine, Ukraine should receive another 13.4 million doses of Pfizer-BioNTech’s vaccine marketed under the tradename of Comirnaty by the end of 2021. Additionally, the shipment of 5.45 million vaccine doses under the COVAX program in 2021 has also been confirmed, he said.
“Thus, the overall number of vaccine doses Ukraine is expected to receive by the end of 2021 is 18.85 million,” Liashko said.
Ukraine is not considering the supply of Johnson & Johnson’s anti-COVID vaccine, negotiations with the company are not underway, Deputy Minister of Health, Chief Sanitary Doctor Ihor Kuzin said.
“Johnson & Johnson’s vaccine supply is not currently being considered and supply negotiations are currently not held,” he told reporters on Monday.
Kuzin said that the vaccine manufacturer “is not proactively communicating.”
“The communication mechanisms that we have used have so far been ineffective,” he said.
As reported, in July 2021, Ukraine registered a vector vaccine against COVID-19 Janssen manufactured by Johnson & Johnson. One dose of Janssen vaccine is sufficient for a complete immunization. It requires a storage temperature of +2 to +8 degrees Celsius.
Earlier, 500 doses of Janssen vaccine were delivered to Ukraine in compliance with the procedure for importing unregistered medicines for vaccination of employees of a private company, which paid its cost, organized delivery and ensured compliance with the temperature regime. Employees of this company work in Alaska in the fishing industry and had to be vaccinated with a U.S.-certified vaccine in order to be allowed into this country.